This topic contains a solution. Click here to go to the answer

Author Question: While monitoring a patient for bleomycin toxicity, the nurse should obtain: 1. bone marrow ... (Read 55 times)

Jkov05

  • Hero Member
  • *****
  • Posts: 556
While monitoring a patient for bleomycin toxicity, the nurse should obtain:
 
  1. bone marrow aspiration results.
  2. pulmonary function studies.
  3. echocardiogram results.
  4. renal function studies.

Question 2

A patient has received carmustine for a brain tumor. When should the nurse expect the neutrophil nadir?
 
  1. 3-5 days
  2. 7-10 days
  3. 10-14 days
  4. 4-6 weeks



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blfontai

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

Correct Answer: 2

Answer to Question 2

Correct Answer: 4




Jkov05

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


fatboyy09

  • Member
  • Posts: 358
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Opium has influenced much of the world's most popular literature. The following authors were all opium users, of varying degrees: Lewis Carroll, Charles, Dickens, Arthur Conan Doyle, and Oscar Wilde.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library